Last reviewed: May 16, 2026
Last updated: May 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Felix Health is a telehealth platform offering GLP-1 prescriptions through a subscription-based business model with standardized monthly fees. Their approach aims to simplify access but operates within specific regulatory and clinical frameworks that differ meaningfully from compounded GLP-1 pathways.
Understanding how different GLP-1 access models work—whether subscription-based telehealth, branded pharmaceuticals, or compounded formulations—helps patients and providers make informed decisions aligned with individual clinical needs, cost tolerance, and medication preferences.
How Felix Health's Business Model Works
Felix Health operates as a direct-to-consumer telehealth platform offering GLP-1 prescriptions through licensed physicians. Their model relies on standardized consultations and flat-rate pricing to streamline access, targeting patients seeking convenience and predictable costs without traditional insurance navigation.
The platform emphasizes simplicity: monthly subscription fees bundle the provider consultation, prescription, and sometimes medication shipment. This model prioritizes speed and consistency but may limit customization in dosing adjustments or medication selection based on individual clinical contexts.
Pricing Structure and Access Comparison
Felix Health's pricing typically ranges from $99 to $299 monthly depending on medication type and whether consultations are included. Comparing total cost of care requires evaluating subscription fees, medication availability, and whether insurance reimbursement is possible through their model versus other pathways.
| Access Model |
Pricing Range |
Medication Types |
Clinical Customization |
| Felix Health Telehealth |
$99–$299/month |
Branded GLP-1 or generic |
Standardized protocol |
| Compounded GLP-1 (503A) |
$129-$369/mo |
Semaglutide, tirzepatide, combinations |
Dose and formulation flexibility |
| Traditional Insurance + Provider |
Variable copay |
Branded or generic |
Individualized clinical oversight |
| Direct-to-Patient Branded |
$150–$400/month |
Single branded option |
Manufacturer guidance |
Clinical Oversight and Prescriber Accountability
Felix Health employs licensed physicians to review patient information and issue prescriptions, meeting basic regulatory requirements. However, the standardized nature of telehealth consultations may not accommodate complex medical histories, polypharmacy concerns, or patients requiring intensive metabolic monitoring.
Compounded GLP-1 pathways through 503A pharmacies function with similar physician oversight but often allow for more granular dose titration and formulation options. Patients with specific clinical needs—such as those with pancreatitis history, multiple comorbidities, or sensitivity to standard dosing—may benefit from discussing compounded alternatives with their provider.
Who This Model Suits and Important Safety Considerations
Felix Health's subscription model works well for patients seeking straightforward GLP-1 access, stable dosing, and predictable costs. It is least suitable for patients with complex medical histories, those requiring frequent dose adjustments, or individuals interested in exploring multiple peptide formulations or biomarker-guided personalization.
Before starting any GLP-1—whether through Felix, compounded pharmacies, or traditional prescribers—patients should discuss contraindications (personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2), current medications, kidney function, and gastrointestinal health with a qualified provider. GLP-1 medications are not appropriate for all patients and require ongoing monitoring.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context for how individual genetic predispositions in GLP-1 and GIP receptor pathways (variants like GLP1R rs6923761, GIPR rs1800437) could relate to baseline metabolism and peptide responsiveness. This information can support a more personalized conversation with a qualified healthcare provider about medication selection and dosing strategy.
The genetic test reveals predispositions in peptide pathway genes and metabolic factors (FTO rs9939609, MC4R rs17782313), but does not predict exact medication response or guarantee specific outcomes. Results should always be interpreted alongside clinical evaluation, lab work, and provider assessment to inform a comprehensive treatment plan.
For patients exploring GLP-1 options, understanding both genetic context and available medication modalities—compounded formulations with dosing flexibility, branded options with standardized protocols, or telehealth subscription models—can help facilitate a more informed decision alongside a licensed healthcare provider.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does Felix Health offer compounded GLP-1 medications?
Felix Health primarily prescribes branded or standard generic GLP-1 medications, not compounded formulations. Patients interested in compounded semaglutide, tirzepatide, or combination peptides should explore licensed 503A compounding pharmacy pathways with provider oversight.
Is Felix Health's subscription model covered by insurance?
Felix Health's direct-pay subscription model typically bypasses insurance entirely, making it self-pay only. This simplifies access but eliminates potential insurance reimbursement that patients might receive through traditional prescriber-pharmacy pathways.
How does Felix Health compare to compounded GLP-1 from PlexusDx?
Felix Health offers standardized telehealth access to branded GLP-1 medications. PlexusDx partners with licensed 503A compounding pharmacies to provide customizable compounded semaglutide and tirzepatide formulations, with optional genetic testing to inform personalization—different regulatory pathways with distinct clinical flexibilities.
What should I ask my provider before choosing a GLP-1 access model?
Discuss your medical history, current medications, kidney function, and any gastrointestinal concerns. Ask whether your provider recommends a standardized GLP-1 protocol, compounded formulations with dosing flexibility, or whether genetic insights into peptide metabolism might inform your selection.
Can genetic testing help me decide between different GLP-1 options?
The Precision Peptide Genetic Test reveals predispositions in GLP-1 and GIP receptor pathways, which may help contextualize individual variability. Results should be discussed with a qualified provider to inform whether compounded formulations, branded options, or other strategies align best with your genetic profile and clinical needs.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Form Health Review: Genetic and Biomarker Context for GLP-1 Selection
Midi Health and Tirzepatide: Program Model, Compounded-Pharmacy